Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$563K Buy
6,053
+2
+0% +$177 ﹤0.01% 1017
2025
Q4
$486K Sell
6,051
-371
-6% -$31.1K ﹤0.01% 1038
2025
Q3
$627K Hold
6,422
﹤0.01% 1009
2025
Q2
$448K Hold
6,422
﹤0.01% 1032
2025
Q1
$319K Buy
+6,422
New +$406K ﹤0.01% 952
2024
Q4
Sell
-2,422
Closed -$254K 1096
2024
Q3
$254K Buy
2,422
+22
+0.9% +$2.57K ﹤0.01% 980
2024
Q2
$341K Hold
2,400
﹤0.01% 938
2024
Q1
$268K Buy
2,400
+400
+20% +$47.7K ﹤0.01% 961
2023
Q4
$259K Hold
2,000
﹤0.01% 976
2023
Q3
$326K Hold
2,000
﹤0.01% 957
2023
Q2
$367K Hold
2,000
﹤0.01% 948
2023
Q1
$267K Buy
+2,000
New +$235K ﹤0.01% 998
2019
Q4
Sell
-17,000
Closed -$291K 1103
2019
Q3
$291K Buy
+17,000
New +$272K ﹤0.01% 1019

Other funds holding ACLS

Gabelli Funds's ACLS Position: Q1 2026 in Review

Gabelli Funds increased its Axcelis (ACLS) stake by 0.03% in Q1 2026, buying an estimated $177 and bringing the position to 6,053 shares worth $563K. The position accounts for ﹤0.01% of the portfolio, ranked #1017.

Gabelli Funds first reported a position in ACLS in Q3 2019 and has held it in 13 quarters since. The position peaked at $627K in Q3 2025. 377 funds tracked by Wall St. Rank hold ACLS as of Q1 2026.

  • Gabelli Funds held 6,053 shares of Axcelis worth $563K as of Q1 2026.
  • Gabelli Funds bought 2 Axcelis shares in Q1 2026, an estimated $177.
  • Axcelis made up ﹤0.01% of Gabelli Funds's portfolio in Q1 2026, its #1017 holding.
  • Gabelli Funds first reported a position in Axcelis in Q3 2019 and has held it in 13 quarters since.
  • Gabelli Funds's Axcelis position peaked at $627K in Q3 2025.
  • 377 funds tracked by Wall St. Rank held Axcelis as of Q1 2026.

Based on Gabelli Funds's 13F filing for Q1 2026, filed 14 May 2026.